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CORRESPONDENCE
Re: ‘Type II Endoleak: Conservative Management Is a Safe
Strategy’
Sidloff et al.1 report an improved overall mortality among
patients with type 2 endoleaks. However, their conclusions
must be interpreted with caution as study design and
consequent selection bias are limiting factors. Moreover, a
causal connection between type 2 endoleaks and improved
survival is implausible and most likely the effect of con-
founders. Although a lower atherosclerotic burden in these
patients has been reported,2 this hypothesis does not ﬁnd
support in the presented data.
Type 2 endoleaks have been associated with occult or
posture dependent type 1 and type 3 endoleaks,3,4 suture line
holes,5 or late fabric failure,6 which lead to outﬂow of blood
from the sac to its’main collaterals. In their cohort, Sidloff et al.
reported six cases of type 1 endoleak among the type 2
endoleak group, which was not statistically signiﬁcant. Never-
theless, although angiography has been demonstrated to be
more discriminating for the diagnosis of occult type 1 or 3
endoleaks,4 it was not routinely performed in the study group.
Type 2 endoleak directed interventions have proven to be
ineffective in arresting aneurysm sac enlargement,7 and
treatment related complications have probably been under
reported in the literature.8 In the cohort presented by Sidloff
et al., interventions were also unsuccessful,1 but the authors’
treatment strategy is not clearly presented. Moreover, data
regarding aneurysm sac dynamics following treatment could
have further elucidated the outcomes of these interventions.
The bottom line is the natural history of type 2 endoleaks
is not clear, their impact on aneurysm related adverse events
is controversial, and optimal management remains to be
established. Moreover, although attempts to resolve type 2
endoleaks remain largely unsuccessful, type 2 endoleaks are
at least associated with an equivalent overall prognosis.
Perhaps, this may be further improved if the consequences
of unnecessary interventions are avoided.
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Re: ‘Type II Endoleak: Conservative Management Is a Safe
Strategy’
Thank you for your interest in this article. An association
between type II endoleak and survival has recently been
described in a similar cohort of patients1; therefore, this
ﬁnding is not unique. We acknowledge that these obser-
vations are unexplained, and possibly secondary to con-
founders, but do not feel that they can be dismissed
without further investigation in independent studies.
Furthermore, we feel that whilst interesting, this ﬁnding is not
the key take-home message from our work, and in-depth
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